Trials / Completed
CompletedNCT06575972
A Clinical Study to Assess the Effects of JoyRise Recovery Powder on Mitigating Alcohol Aftereffects.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Joyrise · Industry
- Sex
- All
- Age
- 35 Years – 54 Years
- Healthy volunteers
- Accepted
Summary
This study assesses the effectiveness of JoyRise Recovery Powder in reducing alcohol aftereffects, cognitive impairment, and anxiousness among participants aged 35-54 who consume alcohol. Participants will be randomly assigned to either the JoyRise group or a placebo group. The study will measure hangover symptoms, cognitive function, and overall well-being through a series of questionnaires and cognitive tests at baseline, 30 minutes after product consumption, and 4 hours later.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | JoyRise Recovery Powder | JoyRise Recovery Powder is a dietary supplement that contains Dihydromyricetin (DHM) and other natural ingredients. It is designed to mitigate the aftereffects of alcohol consumption. Participants will mix one serving in 8-12 oz of water and consume it the morning after alcohol consumption. |
| DIETARY_SUPPLEMENT | Placebo | A placebo solution that is visually and tastefully similar to JoyRise Recovery Powder but contains no active ingredients. It will be mixed in 8-12 oz of water and consumed the morning after alcohol consumption. |
Timeline
- Start date
- 2024-06-25
- Primary completion
- 2024-08-01
- Completion
- 2024-08-01
- First posted
- 2024-08-28
- Last updated
- 2024-08-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06575972. Inclusion in this directory is not an endorsement.